Ilyas Sahin, M.D., on the potential use of Northstar Response in GI cancer
In an OncLive interview, Ilyas Sahin, M.D., discussed the Northstar Response in patients with advanced gastrointestinal cancer undergoing treatment.
All Posts by
In an OncLive interview, Ilyas Sahin, M.D., discussed the Northstar Response in patients with advanced gastrointestinal cancer undergoing treatment.
Researchers shed light on a pivotal mechanism regarding melanoma cells’ response to stress induced by chemotherapy agents.
Dr. Lee will ensure high-quality data, rigorous and reproducible analyses, and effective reporting, fostering collaborative research.
The study details novel method to create personalized mRNA-based vaccines to target brain tumors.
The national training program aims to equip community health educators to effectively serve their cancer centers and communities.
The project aims to improve the physical, emotional and mental well-being of patients during their journey through survivorship.
UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
The UF Health Cancer Center celebrates a new year.
The preliminary findings indicate that the technique could allow physicians to assess patients’ tumor burden without invasive tumor biopsies.
The goal of the project led by Wesley Bolch, Ph.D., is to advance cancer care by enhancing the effectiveness of radiopharmaceutical therapy.